azetidyl-2-carboxylic acid has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geot, WM; Horikoshi, S; Suzuki, Y; Takahashi, H; Tanifuji, C; Tomino, Y | 1 |
| Kinami, Y; Sakata, N; Takata, M | 1 |
2 other study(ies) available for azetidyl-2-carboxylic acid and Cirrhosis
| Article | Year |
|---|---|
Beneficial effects of combination therapy with olmesartan and azelnidipine in murine polycystic kidneys.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Azetidinecarboxylic Acid; Blotting, Western; Calcium Channel Blockers; Dihydropyridines; Drug Synergism; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Imidazoles; Immunohistochemistry; Kidney; Mice; NADPH Oxidases; Nitric Oxide Synthase Type III; Polycystic Kidney Diseases; Tetrazoles | 2009 |
Effects of antifibrotic substances on pancreatic fibrosis following acute necrotizing pancreatitis.
Topics: Animals; Azetidinecarboxylic Acid; Azetines; Colchicine; Fibrosis; Hydroxyproline; Male; Pancreas; Pancreatitis; Rats; Rats, Inbred Strains | 1986 |